Concepedia

Maximilian Lombardo

ML

4

Publications

335

Citations

4

H-Index

2015

Active since

Affiliations

Columbia University(Current)

Chan Zuckerberg Initiative (United States)

Maximilian Lombardo is an author at Columbia University specializing in medicine, tumor biology, and drug discovery.

Top concepts

MedicineOmicsBiologyPathologyImmunologyEngineeringBiochemistryCell BiologyData SciencePharmacology

Publications per year

2015–2024

4

Publications

4

cellxgene: a performant, scalable exploration platform for high dimensional sparse matrices

Colin Megill, Bruce Martin, Charlotte A. Weaver et al. · 2021 · 201 citations · Full text

Engineering, Machine Learning, Spatial Omics +28

Dual Targeting of Protein Degradation Pathways with the Selective HDAC6 Inhibitor ACY-1215 and Bortezomib Is Synergistic in Lymphoma

Jennifer E. Amengual, Paul Johannet, Maximilian Lombardo et al. · Clinical Cancer Research · 2015 · 90 citations

Mechanisms of Acquired Drug Resistance to the HDAC6 Selective Inhibitor Ricolinostat Reveals Rational Drug-Drug Combination with Ibrutinib

Jennifer E. Amengual, Sathyen A. Prabhu, Maximilian Lombardo et al. · Clinical Cancer Research · 2016 · 28 citations · Full text

Drug Target, Acquired Drug Resistance, Immunology +19

Defining and benchmarking open problems in single-cell analysis

Malte D. Luecken, Scott Gigante, Daniel B. Burkhardt et al. · 2024 · 16 citations · Full text

Rows per page

1–4 of 4